Hamill John P. (CIK 1716213) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-16). Recent activity: Buy APRE (10,095 shares), Buy APRE (5,700 shares), Buy APRE (5,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-16 | Aprea Therapeutics, Inc. (APRE) | SrVP/CFO/Prin Fin & Acct Ofcr | Buy | 10,095 | $0 |
| 2026-02-02 | Aprea Therapeutics, Inc. (APRE) | SrVP/CFO/Prin Fin & Acct Ofcr | Buy | 5,700 | $5,073 |
| 2025-12-11 | Aprea Therapeutics, Inc. (APRE) | SrVP/CFO/Prin Fin & Acct Ofcr | Buy | 5,000 | $5,850 |
来源：SEC Form 4 申报文件 · 截至 2026-03-16